Approval · Notice of Compliance 27090 · 2021
LOSEC: Notice of Compliance 27090
Issued November 24, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27090
- Date
- November 24, 2021
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the layout of the mock-up bottle label.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOSEC | Not yet assigned | — |
Medicinal ingredients
- OMEPRAZOLE 20 MG per CAP